RANKL maintains bone homeostasis through c-fos-dependent induction of interferon-β

Nature

Volumn 416, Issue 6882, 2002, Pages 744-749

  Takayanagi, Hiroshi ^a   Kim, Sunhwa ^a   Matsuo, Koichi ^c,d   Suzuki, Hiroshi ^a   Suzuki, Tomohiko ^e   Sato, Kojiro ^a   Yokochi, Taeko ^a   Oda, Hiromi ^b   Nakamura, Kozo ^b   Ida, Nobutaka ^e   Wagner, Erwin F ^c   Taniguchi, Tadatsugu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^d NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^e TORAY INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; GENES; SIGNAL PROCESSING; VIRUSES;

HOMEOSTASIS; PATHOGENESIS;

BONE;

BETA INTERFERON; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; TRANSCRIPTION FACTOR;

MEDICINE;

ANIMAL CELL; ARTICLE; AUTOREGULATION; BONE DISEASE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE INDUCTION; HOMEOSTASIS; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; ONCOGENE C FOS; OSTEOCLAST; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BONE AND BONES; BONE DISEASES, METABOLIC; BONE REMODELING; CARRIER PROTEINS; HOMEOSTASIS; INTERFERON-BETA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MUTATION; OSTEOBLASTS; OSTEOCLASTS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, INTERFERON; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

ANIMALIA;

EID: 0037129205     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/416744a     Document Type: Article

References (30)

1. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
2. Therapeutic approaches to bone diseases
3. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
4. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis
5. Modulation of osteoclast differentiation and function by the new members ofthe tumor necrosis factor receptor and ligand families
6. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis
7. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
8. Fosll is a transcriptional target of c-Fos during osteoclast differentiation
9. Genetic control of skeletal development
10. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD 40, and LPS signaling
11. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice
12. Bone and haematopoietic defects in mice lacking c-fos
13. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
14. Cell biology of the osteoclast
15. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
16. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
17. Functional role of type I and type II interferons in antiviral defense
18. Cross talk between interferon-γ and -α/β signaling components in caveolar membrane domains
19. IRF family of transcription factors as regulators of host defense
20. How cells respond to interferons
21. The elF-2 α protein kinases, regulators of translation in eukaryotes from yeasts to humans
22. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase
23. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo
24. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction
25. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts
26. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover
27. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development
28. Essential and non-redundant roles of p48 (ISGF3γ) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies
29. Targeted disruption of the Statl gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
30. 8 T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling